Stem Cell Blog

Употребата на матичните клетки од папочна врвца рапидно се зголемува. Пред 10 години крвта од папочна врвца можеше да лекува околу 40 состојби, но денес таа бројка е над 80. Со нетрпение очекуваме нови терапии за болести и нарушувања како што се дијабет, аутизам и мозочен удар, можете да бидете во тек со најновите случувања во регенеративната медицина на нашиот блог за матични клетки.



sangharsh-lohakare-Iy7QyzOs1bo-unsplash-980x551-1.jpg

Medical regulators in the UK have approved a gene-editing treatment involving bone marrow stem cells designed to cure two blood diseases, including sickle cell disease, in what is a world first.

The therapy, called Casgevy, has been given the green light by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat sickle cell disease and beta thalassemia, two painful blood conditions. [1]


Stem-Cells-dividing_medium.jpeg

20/01/2024 BlogNews

Stem cells and related research are all over the news, as amazing new applications for them are being studied, discovered and applied all the time.

This means you may have already heard of them. You may even know exactly what they are. But for anyone who wants a more in-depth knowledge of these potentially life-saving cells, read on.


shutterstock_1181843014-1080x675-1.jpg

20/01/2024 BlogNews

According to the first large-scale study of its kind, pregnant women are at no greater risk of being admitted to hospital with severe coronavirus symptoms than other women.

The study examined more than 420 expectant mothers who were admitted to hospital with critical cases of COVID-19 between March 1 and April 14. Results show that only 10% of them required treatment in ICU. This figure is comparable to the statistics for other woman who are not pregnant.


WHO-Stabilitech-Blog.png

20/01/2024 BlogNews

The sister company of Cells4Life, Stabilitech Biopharma, have been formally recognised by the World Health Organisation (WHO) as an official vaccine developer.

Stabilitech board member Dr Jeff Drew, who is also the co-founder of Cells4Life, noted: “The WHO is a pivotal player when it comes to vaccines, it sets all of the guidelines adopted by bio-pharmaceutical companies for vaccines development.


Stabilitech-COVID-19-vaccine.png

20/01/2024 BlogNews

The sister company of Cells4Life – Stabilitech – has joined the race to create a vaccine for the coronavirus which has put the country into lockdown and is currently raising £6 million in funding to finance the next crucial stage of development.

Stabilitech, a UK biotechnology company which develops next-generation vaccines and biopharmaceuticals, is seeking an investment of £6 million to fund clinical trials and manufacturing of an oral COVID-19 capsule vaccine.


AABB.jpg

20/01/2024 BlogNews

This month, we celebrate achieving AABB accreditation – a globally renowned certification that recognises standards, practices and quality management in the collection, processing and storage of cord blood.

This is just the latest quality standard that we’ve attained. Most importantly we are licenced by the UK regulator the Human Tissue Authority (HTA) and have been since its formation. We are also authorised by the Financial Conduct Authority and approved by the National Association of Phlebotomists.